LONDON, 6 December 2007 – Panmure Gordon & Co plc (PMR.L) is pleased to announce that it has been selected as nominated adviser and sole corporate broker to Summit plc (SUMM.L), a leading biotechnology company based in Oxford, UK.

“Panmure Gordon is delighted with this appointment. Founded in 2003, Summit is making an important contribution to international drug development and discovery programs, especially in the treatment of neuro-disorders. Our appointment as NOMAD and sole broker underlines our commitment to adding value to companies in this sector,” said executive director, Andrew Burnett.